APA (7th ed.) Citation

L, Y., J, Z., Z, R., & K, S. (2026). Case Report: Upadacitinib and apremilast combination therapy for guselkumab-induced paradoxical eczema in psoriasis. Frontiers in immunology, 17, 1696255. https://doi.org/10.3389/fimmu.2026.1696255

Chicago Style (17th ed.) Citation

L, Yang, Zhou J, Ruan Z, and Shi K. "Case Report: Upadacitinib and Apremilast Combination Therapy for Guselkumab-induced Paradoxical Eczema in Psoriasis." Frontiers in Immunology 17 (2026): 1696255. https://doi.org/10.3389/fimmu.2026.1696255.

MLA (9th ed.) Citation

L, Yang, et al. "Case Report: Upadacitinib and Apremilast Combination Therapy for Guselkumab-induced Paradoxical Eczema in Psoriasis." Frontiers in Immunology, vol. 17, 2026, p. 1696255, https://doi.org/10.3389/fimmu.2026.1696255.